Mammography Market Size
The Global Mammography Market reached USD 2.5 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 5.3 billion in 2031. The global mammography market is expected to exhibit a CAGR of 10.1% during the forecast period 2024-2031. Mammography is a diagnostic technique for imaging that uses low-dose X-rays to create detailed images of breast tissue.
It is used primarily for breast cancer screening and detection, but can also be used to diagnose and evaluate other breast conditions, such as lumps or cysts. During a mammogram, the breast is compressed between two plates to obtain the images.
Mammography is a non-invasive and relatively low-risk procedure, but it can cause some discomfort or pain for some women. Regular mammograms are recommended for women over the age of 40, or for younger women who have a high risk of breast cancer. Furthermore, the increasing prevalence of breast cancer, technological advancement in mammography equipment and growing health concerns and government initiatives are the factors expected to drive over the forecast period.
Market Summary
| Metrics | Details |
| CAGR | 10.1% |
| Size Available for Years | 2022-2031 |
| Forecast Period | 2024-2031 |
| Data Availability | Value (US$) |
| Segments Covered | Type, Dimension, Application, End User and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Orthopedic Surgery key Insights. |
For more Insights - Request Free Sample
Market Dynamics
Increasing Adoption of Mammography is Expected to Drive Mammography Market Growth
The Mammography Quality Standards Act (MQSA) program of the U.S. Food and Drug Administration (FDA), which inspects breast imaging facilities and certifies each imaging system, estimated that more than 39.6 Billion breast exams were performed in 2022. The FDA reported that as of January 2023, there were more than 24,500 accredited mammography systems and 8,808 certified breast imaging institutions in the United States.
Moreover, the most significant development in mammography is the evolution of fundamental imaging technology. For over 20 years, full-field digital mammography (FFDM) has been the industry standard for breast imaging, but digital breast tomosynthesis (DBT) devices, often known as 3D mammography, are quickly replacing FFDM.
According to the FDA's MQSA figures as of January 2023, DBT systems now account for 46% of mammography systems in the United States. According to FDA statistics, around 1,000 new tomo breast imaging systems are installed each year, which suggests that DBT will most likely replace the vast majority of FFDM mammography systems within the following ten years. Thus, owing to the above factors, the market is expected to drive over the forecast period.
The Rising Role of AI in Mammography is Expected to Drive Mammography Market Growth
Advancements in technology and computer programming have led to an increased involvement of computer-automated analyses in medical image interpretation. This is driven by the need for more accurate and efficient workflows in imaging interpretation. In the field of breast imaging, FDA-approved artificial intelligence (AI) algorithms are being employed to support radiologists.
One application of AI in breast imaging is automated breast density assessment, which eliminates variations caused by human readers. Additionally, AI is utilized to scan all breast photos automatically, identifying regions of interest that may include suspicious malignancies. By automatically identifying breast cancer lesions and marking them as areas of interest on mammograms, AI provides radiologists with a better understanding of where to focus their attention.
Furthermore, AI can assist radiologists in prioritizing exams for review. By employing AI to conduct initial examinations of mammograms and determine if they appear normal, radiologists can prioritize which exams require immediate attention and which ones may be more challenging.
As breast imaging exams transition from conventional four-image mammography studies to larger 3D digital breast tomosynthesis (DBT) exams consisting of 50 or more images, the role of AI is expected to become increasingly crucial. Some medical centers are already utilizing AI to identify images within these datasets that warrant further examination, thereby expediting reading times. Thus, owing to the above factors, the market is expected to drive over the forecast period.
The High Cost of Mammography Equipment is Expected to Hamper Mammography Market Growth
The introduction of relatively new and more costly 3D technology has impacted the average pricing of digital mammography devices. According to ECRI, these devices typically range from $200,000 to $500,000. The 3D systems, known for their improved accuracy, have an average cost of around $430,000, while the 2D systems are priced approximately 30% lower. Thus, owing to the above factors, the market is expected to hamper over the forecast period.
Market Segment Analysis
The global mammography market is segmented based on type, dimension, application, end user and region.
Owing to Increasing the Need for Additional Screening, the 3D Segment Accounted for Approximately 61.6% of the Mammography Market Share
3D mammography (breast tomosynthesis) is an imaging technique that combines multiple X-rays of the breast to create a three-dimensional image of the breast. A 3D mammogram is used to look for breast cancer in people who have no signs or symptoms.
3D mammograms have some advantages over 2D mammograms. Among other things, 3D mammograms improve doctors' ability to accurately diagnose breast cancer, find small tumors that have been hidden on a 2D mammogram, provide clearer images of abnormalities in dense breasts and reduce women's number of calls back for further testing for false alarms.
For instance, Hologic, Inc., the revolutionary Selenia Dimensions system has set the new standard in mammography screening, offering exceptionally sharp images, seamless transitions between imaging modes, sophisticated user tools that simplify operation, advanced clinical applications and the world's first and only tomosynthesis-guided biopsy.
Furthermore, hospitals and diagnostic clinics are transitioning to 3D systems due to several benefits, as 2D systems are often ineffective in detecting all signs of cancer, increasing the need for additional screening, which in turn increases overall diagnostic costs.
Similarly, on October 13, 2021, as part of Breast Cancer Awareness Month, Penn Medicine offered free breast cancer screenings to needy women over the age of 40 with no insurance required. Screening Bus staff in the Save-A-Lot parking lot and courtesy of Deliverance Evangelistic Church across from Murrell Dobbins Career and Technical Education High School on W. Lehigh Ave. 2101 provided individual 10-minute exams, screening exams, a private dressing room and Spanish translation services.
The screening event took place on weekdays from Monday 18 October to Friday 29 October from 9 a.m. to 7 p.m. Thus, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.
Market Geographical Share
North America Accounted for Approximately 38.5% of the Market Share in 2022, Owing to the Increasing Cases, Awareness Efforts by Distinct Entities and Market Developments
The increasing cases, awareness efforts by distinct entities and market developments in this region are the factors expected to drive the North American region over the forecast period. For instance, on October 26, 2022, The Breast Cancer Research Foundation (BCRF) launched its Global Data Hub, an innovative, centralized collection of breast cancer research data that is expected to dramatically speed up new studies and supplement the effect of all BCRF investments.
Likewise, on January 26, 2023, Play for P.I.N.K. (PFP) a non-profit organization, declared a record-breaking $5 million funding to Breast Cancer Research Foundation (BCRF) to fund effective breast cancer research in 2023. With this historic funding, PFP will aid 20 BCRF investigators.
Mammography Market Key Players
The major global players in the market include Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., General Medical Merate SpA, Koninklijke Philips NV, Metaltronica SpA, Konica Minolta Inc., Planmed Oy, Siemens Healthineers, Carestream Health and Canon Medical Systems among others.
Russia-Ukraine Conflict Analysis
The conflict between Russia and Ukraine had various impacts on the mammography market, particularly in the affected regions. The conflict led to the destruction or disruption of healthcare facilities, including those equipped with mammography systems. This resulted in limited access to mammography services for the local population.
During times of conflict, healthcare funding was redirected towards immediate humanitarian needs and military efforts, which resulted in reduced financial resources allocated to healthcare infrastructure and equipment, including mammography systems. Conflict often leads to population displacement and migration. This impacted the demand for and utilization of mammography services as people are forced to leave their homes and may not have access to healthcare facilities with mammography capabilities in their new locations.
Conflict often leads to population displacement and migration. This impacted the demand for and utilization of mammography services as people are forced to leave their homes and may not have access to healthcare facilities with mammography capabilities in their new locations. In regions directly affected by the conflict, research and development efforts related to mammography technology and advancements may be hampered due to the disruption of scientific institutions, limited resources and brain drain.
Key Developments
- On March 14, 2022, Metaltronica SpA announced the launch of its highly technologically advanced mobile mammography unit. It is possible to expand the provision of prevention services by using a mobile mammography device to implement screening programs for early breast cancer diagnosis.
- On April 25, 2022, DetectedX and GE Healthcare formed an educational agreement to increase access to the Radiology Online Learning Platform from DetectedX, fostering global excellence in diagnostic accuracy. The online self-assessment courses were created to enhance radiologists' capacity to accurately identify breast lesions in 2D and 3D mammography and they have been demonstrated to reduce recall rates and improve cancer detection by over 34%.
- On May 15, 2023, TGH Imaging increased patient access across four counties for breast cancer screening by adding Genius 3D Mammography exams made by Hologic to 18 locations in Hillsborough, Pasco, Pinellas and Palm Beach counties. Also called tomosynthesis, 3D mammography is a form of mammography that creates a 3D image of the breast that can better detect breast cancer.
Why Purchase the Report?
- To visualize the global mammography market segmentation based on the type, dimension, application, end user and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of mammography market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The Global Mammography Market Report Would Provide Approximately 69 Tables, 66 Figures and 195 Pages.
Target Audience 2024
- Manufacturers / Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
